Building on the success of three previous sessions in establishing a high-level academic exchange platform, the fourth session of the "Interdisciplinary Joint Symposium Series on Metabolic Syndrome and Diabetes" was successfully held online on September 29,2025.
Building upon the previous three sessions' focus on "personalized treatment" and "complication prevention", this session expanded its perspective to "cutting-edge advancements in metabolic diseases and multidisciplinary integration". The aim is to translate the latest scientific breakthroughs into clinical drivers, providing better solutions for complex patients.
With the rapid development of precision medicine and digital health, the diagnosis and treatment models for metabolic diseases are undergoing profound transformations.
How to integrate innovative technologies such as artificial intelligence, genetic testing, and remote monitoring into daily clinical practice, and strengthen multidisciplinary collaboration to address complex clinical challenges, has become an urgent topic for physicians to explore.
To this end, the fourth conference invited leading figures from within the province in the fields of endocrinology, precision medicine, pharmacy, and chronic disease management to discuss future directions.
The core agenda of this conference focused on several cutting-edge topics: "Diabetes Diagnosis and Treatment Guidelines", "Application of Diabetic Foot Disease Treatment", "Interpretation of Expert Consensus on Diabetes Subtyping Diagnosis in China", and "Dynamic Blood Glucose Monitoring Combined with Insulin Pump Continuous Injection for Diabetes Management". During the conference, speakers shared the most advanced research findings and valuable clinical practices in the field. The online interactive session sparked lively discussions, with intellectual exchanges generating numerous sparks of wisdom.
Participants unanimously expressed that the conference content was novel and highly practical, providing invaluable references for future clinical and research work.
Building on past achievements and paving the way for future innovations.
This seminar series has consistently upheld the mission of "promoting interdisciplinary integration and serving frontline clinical practice."
The successful fourth session not only delivered another academic feast for specialists in endocrinology, cardiology, nephrology, general medicine, and pharmacy, but also signifies our entry into a new era of precision, diversity, and collaboration in metabolic disease research.
The series will continue to cultivate this high-quality academic platform, pooling expertise to collectively advance the high-quality development of chronic disease prevention and control in China.
